Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'MATRIX METALLOPROTEINASE INHIBITOR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 105 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Zogakis, TG; Libutti, SK
      General aspects of anti-angiogenesis and cancer therapy

      EXPERT OPINION ON BIOLOGICAL THERAPY
    2. Reichenberger, F; Eickelberg, O; Wyser, C; Perruchoud, AP; Roth, M; Tamm, M
      Distinct endobronchial expression of matrix-metalloproteinases (MMP) and their endogenous inhibitors in lung cancer

      SWISS MEDICAL WEEKLY
    3. Moss, ML; White, JM; Lambert, MH; Andrews, RC
      TACE and other ADAM proteases as targets for drug discovery

      DRUG DISCOVERY TODAY
    4. Midgley, R; Kerr, D
      Conventional cytotoxic and novel therapeutic concepts in colorectal cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    5. Suzuki, K; Nakayama, H; Doi, K
      Kinetics of matrix metalloproteinases and their regulatory factors in mercuric chloride-induced tubulointerstitial fibrosis in Brown Norway rats

      EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
    6. Pross, M; Lippert, H; Mantke, R; Kruger, S; Gunther, T; Marusch, F; Halangk, W; Schulz, HU
      A proteinase inhibitor decreases tumor growth in a laparoscopic rat model

      SURGICAL ENDOSCOPY-ULTRASOUND AND INTERVENTIONAL TECHNIQUES
    7. Ohta, M; Konno, H; Tanaka, T; Baba, M; Kamiya, K; Oba, K; Kaneko, T; Syouji, T; Igarashi, A; Nakamura, S
      Effect of combination therapy with matrix metalloproteinase inhibitor MMI-166 and mitomycin C on the growth and liver metastasis of human colon cancer

      JAPANESE JOURNAL OF CANCER RESEARCH
    8. Nakamura, Y; Sato, K; Wakimoto, N; Kimura, F; Okuyama, A; Motoyoshi, K
      A new matrix metalloproteinase inhibitor Sl-27 induces apoptosis in several human myeloid leukemia cell lines and enhances sensitivity to TNF alpha-induced apoptosis

      LEUKEMIA
    9. Korn, EL; Arbuck, SG; Pluda, JM; Simon, R; Kaplan, RS; Christian, MC
      Clinical trial designs for cytostatic agents: Are new approaches needed?

      JOURNAL OF CLINICAL ONCOLOGY
    10. Yao, J; Morioka, T; Li, B; Oite, T
      Endothelin is a potent inhibitor of matrix metalloproteinase-2 secretion and activation in rat mesangial cells

      AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY
    11. Heath, EI; O'Reilly, S; Humphrey, R; Sundaresan, P; Donehower, RC; Sartorius, S; Kennedy, MJ; Armstrong, DK; Carducci, MA; Sorensen, JM; Kumor, K; Kennedy, S; Grochow, LB
      Phase I trial of the matrix metalloproteinase inhibitor BAY12-9566 in patients with advanced solid tumors

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    12. Pepper, MS
      Extracellular proteolysis and angiogenesis

      THROMBOSIS AND HAEMOSTASIS
    13. Shlopov, BV; Stuart, JM; Gumanovskaya, ML; Hasty, KA
      Regulation of cartilage collagenase by doxycycline

      JOURNAL OF RHEUMATOLOGY
    14. Alves, F; Borchers, U; Padge, B; Augustin, H; Nebendahl, K; Kloppel, G; Tietze, LF
      Inhibitory effect of a matrix metalloproteinase inhibitor on growth and spread of human pancreatic ductal adenocarcinoma evaluated in an orthotopic severe combined immunodeficient (SCID) mouse model

      CANCER LETTERS
    15. Weiss, YG; Bellin, L; Kim, PK; Andrejko, KM; Haaxma, CA; Raj, N; Furth, EE; Deutschman, CS
      Compensatory hepatic regeneration after mild, but not fulminant, intraperitoneal sepsis in rats

      AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
    16. Holst-Hansen, C; Low, JA; Stephens, RW; Johnson, MD; Carmeliet, P; Frandsen, TL; Brunner, N; Dickson, RB
      Increased stromal expression of murine urokinase plasminogen activator in a human breast cancer xenograft model following treatment with the matrix metalloprotease inhibitor, batimastat

      BREAST CANCER RESEARCH AND TREATMENT
    17. Leppert, D; Lindberg, RLP; Kappos, L; Leib, SL
      Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis

      BRAIN RESEARCH REVIEWS
    18. Chen, J; Raj, N; Kim, P; Andrejko, KM; Deutschman, CS
      Intrahepatic nuclear factor-kappa B activity and alpha(1)-acid glycoprotein transcription do not predict outcome after cecal ligation and puncture inthe rat

      CRITICAL CARE MEDICINE
    19. Ozerdem, U; Mach-Hofacre, B; Keefe, K; Pham, T; Soules, K; Appelt, K; Freeman, WR
      The effect of prinomastat (AG3340), a synthetic inhibitor of matrix metalloproteinases, on posttraumatic proliferative vitreoretinopathy

      OPHTHALMIC RESEARCH
    20. Kolomecki, K; Stepien, H; Bartos, M; Narebski, J
      Evaluation of MMP-1, MMP-8, MMP-9 serum levels in patients with adrenal tumors prier to and after surgery

      NEOPLASMA
    21. Jantova, S; Urbancikova, M; Maliar, T; Mikulasova, M; Rauko, P; Cipak, L; Kubikova, J; Stankovsky, S; Spirkova, K
      Biological activity of some 4-anilinoquinazolines: cytotoxic, genotoxic and antiprotease effects, induction of necrosis and changes of actin cytoskeleton

      NEOPLASMA
    22. Bjornland, K; Bratland, A; Rugnes, E; Pettersen, S; Johansen, HT; Aasen, AO; Fodstad, O; Ree, AH; Maelandsmo, GM
      Expression of matrix metalloproteinases and the metastasis-associated geneS100A4 in human neuroblastoma and primitive neuroectodermal tumor cells

      JOURNAL OF PEDIATRIC SURGERY
    23. Stratmann, B; Farr, M; Tschesche, H
      MMP-TIMP interaction depends on residue 2 in TIMP-4

      FEBS LETTERS
    24. Corbel, M; Lanchou, JM; Germain, N; Malledant, Y; Boichot, E; Lagente, V
      Modulation of airway remodeling-associated mediators by the antifibrotic compound, pirfenidone, and the matrix metalloproteinase inhibitor, batimastat, during acute lung injury in mice

      EUROPEAN JOURNAL OF PHARMACOLOGY
    25. Yoshikawa, T; Tsuburaya, A; Kobayashi, O; Sairenji, M; Motohashi, H; Yanoma, S; Noguchi, Y
      Intratumoral concentrations of tissue inhibitor of matrix metalloproteinase 1 in patients with gastric carcinoma - A new biomarker for invasion and its impact on survival

      CANCER
    26. Seandel, M; Noack-Kunnmann, K; Zhu, D; Aimes, RT; Quigley, JP
      Growth factor-induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagen

      BLOOD
    27. Liekens, S; De Clercq, E; Neyts, J
      Angiogenesis: regulators and clinical applications

      BIOCHEMICAL PHARMACOLOGY
    28. Aslam, N; Marino, CR
      Malignant ascites - New concepts in pathophysiology, diagnosis, and management

      ARCHIVES OF INTERNAL MEDICINE
    29. El Yazal, J; Pang, YP
      Proton dissociation energies of zinc-coordinated hydroxamic acids and their relative affinities for zinc: Insight into design of inhibitors of zinc-containing proteinases

      JOURNAL OF PHYSICAL CHEMISTRY B
    30. Bramhall, SR
      Novel non-operative treatment and treatment strategies in pancreatic cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    31. Desoize, B; Jardillier, JC
      Multicellular resistance: a paradigm for clinical resistance?

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    32. Yamada, A; Uegaki, A; Nakamura, T; Ogawa, K
      ONO-4817, an orally active matrix metalloproteinase inhibitor, prevents lipopolysaccharide-induced proteoglycan release from the joint cartilage in guinea pigs

      INFLAMMATION RESEARCH
    33. Beuche, W; Yushchenko, M; Mader, M; Maliszewska, M; Felgenhauer, K; Weber, F
      Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis

      NEUROREPORT
    34. Nemunaitis, J; Cox, J; Hays, S; Meyer, W; Kebart, R; Ognoskie, N; Courtney, A; Yu, Y; Rasmussen, H; Tong, A
      Prognostic role of K-ras in patients with progressive colon cancer who received treatment with Marimastat (BB2516)

      CANCER INVESTIGATION
    35. Sherer, DM; Eliakim, R; Abulafia, O
      The role of angiogenesis in the accumulation of peritoneal fluid in benignconditions and the development of malignant ascites in the female

      GYNECOLOGIC AND OBSTETRIC INVESTIGATION
    36. Josephs, MD; Bahjat, FR; Fukuzuka, K; Ksontini, R; Solorzano, CC; Edwards, CK; Tannahill, CL; MacKay, SLD; Copeland, EM; Moldawer, LL
      Lipopolysaccharide and D-galactosamine-induced hepatic injury is mediated by TNF-alpha and not by Fas ligand

      AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
    37. Nowak, M; Gaines, GC; Rosenberg, J; Minter, R; Bahjat, FR; Rectenwald, J; MacKay, SLD; Edwards, CK; Moldawer, LL
      LPS-induced liver injury in D-galactosamine-sensitized mice requires secreted TNF-alpha and the TNF-p55 receptor

      AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
    38. Reijneveld, JC; Voest, EE; Taphoorn, MJB
      Angiogenesis in malignant primary and metastatic brain tumors

      JOURNAL OF NEUROLOGY
    39. Eatock, MM; Schatzlein, A; Kaye, SB
      Tumour vasculature as a target for anticancer therapy

      CANCER TREATMENT REVIEWS
    40. Yoshikawa, T; Tsuburaya, A; Kobayashi, O; Sairenji, M; Motohashi, H; Yanoma, S; Noguchi, Y
      Prognostic value of tissue inhibitor of matrix metalloproteinase-1 in plasma of patients with gastric cancer

      CANCER LETTERS
    41. Matsuoka, T; Yashiro, M; Sawada, T; Ishikawa, T; Ohira, M; Chung, KHY
      Inhibition of invasion and lymph node metastasis of gastrointestinal cancer cells by R-94138, a matrix metalloproteinase inhibitor

      ANTICANCER RESEARCH
    42. Fajardo, I; Diez, E; Rodriguez-Nieto, S; Rodriguez-Caso, C; Quesada, AR; Sanchez-Jimenez, F; Medina, MA
      Effects of genistein and 2-methoxyestradiol on matrix metalloproteinases and their inhibitors secreted by Ehrlich ascites tumor cells

      ANTICANCER RESEARCH
    43. Engers, R; Gabbert, HE
      Mechanisms of tumor metastasis: cell biological aspects and clinical implications

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    44. Siemann, DW; Warrington, KH; Horsman, MR
      Targeting tumor blood vessels: an adjuvant strategy for radiation therapy

      RADIOTHERAPY AND ONCOLOGY
    45. Griffioen, AW; Molema, G
      Angiogenesis: Potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation

      PHARMACOLOGICAL REVIEWS
    46. Kurohane, K; Namba, Y; Oku, N
      Liposomes modified with a synthetic Arg-Gly-Asp mimetic inhibit lung metastasis of B16BL6 melanoma cells

      LIFE SCIENCES
    47. Simeon, A; Emonard, H; Hornebeck, W; Maquart, FX
      The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures

      LIFE SCIENCES
    48. Santibanez-Gallerani, AS; Barber, AE; Williams, SJ; Zhao, Y; Shires, GT
      Hepatic integrity dependent on matrix metalloproteinase inhibition, not tumor necrosis factor alpha or different bleeding rates

      JOURNAL OF SURGICAL RESEARCH
    49. Lee, PPH; Hwang, JJ; Murphy, G; Ip, MM
      Functional significance of MMP-9 in tumor necrosis factor-induced proliferation and branching morphogenesis of mammary epithelial cells

      ENDOCRINOLOGY
    50. Hamada, T; Arima, N; Shindo, M; Sugama, K; Sasaguri, Y
      Suppression of adjuvant arthritis of rats by a novel matrix metalloproteinase-inhibitor

      BRITISH JOURNAL OF PHARMACOLOGY
    51. Mempel, M; Schmidt, T; Boeck, K; Brockow, K; Stachowitz, S; Fesq, H; Schafer, T; Thomsen, S; Schnopp, C; Ring, J; Probst, R; Luppa, P; Abeck, D
      Changes in collagen I and collagen III metabolism in patients with generalized atopic eczema undergoing medium-dose ultraviolet A1 phototherapy

      BRITISH JOURNAL OF DERMATOLOGY
    52. Bord, S; Horner, A; Beeton, CA; Hembry, RM; Compston, JE
      Tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) distribution in normal and pathological human bone

      BONE
    53. Koivunen, E; Arap, W; Valtanen, H; Rainisalo, A; Medina, OP; Heikkila, P; Kantor, C; Gahmberg, CG; Salo, T; Konttinen, YT; Sorsa, T; Ruoslahti, E; Pasqualini, R
      Tumor targeting with a selective gelatinase inhibitor

      NATURE BIOTECHNOLOGY
    54. Shi, Y; Patel, S; Niculescu, R; Chung, WS; Desrochers, P; Zalewski, A
      Role of matrix metalloproteinases and their tissue inhibitors in the regulation of coronary cell migration

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    55. Foda, HD; George, S; Rollo, E; Drews, M; Conner, C; Cao, J; Panettieri, RA; Zucker, S
      Regulation of gelatinases in human airway smooth muscle cells: mechanism of progelatinase A activation

      AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
    56. Shattuck-Brandt, RL; Lamps, LW; Goss, KJH; DuBois, RN; Matrisian, LM
      Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms

      MOLECULAR CARCINOGENESIS
    57. Murawaki, Y; Ikuta, Y; Idobe, Y; Kawasaki, H
      Serum matrix metalloproteinase-1 in patients with chronic viral hepatitis

      JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    58. Schiefer, D; Gottstein, C; Diehl, V; Engert, A
      Anti-angiogenesis: a new approach in cancer therapy?

      MEDIZINISCHE KLINIK
    59. Drevs, J; Droll, A; Mross, K; Unger, C
      Angiogenesis inhibition: Drugs in clinical trials

      ONKOLOGIE
    60. Kroegel, C; Forster, M; Hafner, D; Reinhard-Grahmann, P; Warner, JA; Braun, R
      Immunologic and molecular aspects of airways remodelling in asthma

      ALLERGOLOGIE
    61. Sakamoto, A; Oda, Y; Iwamoto, Y; Tsuneyoshi, M
      Expression of membrane type 1 matrix metalloproteinase, matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 in human cartilaginoustumors with special emphasis on mesenchymal and dedifferentiated chondrosarcoma

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    62. Knittel, T; Mehde, M; Kobold, D; Saile, B; Dinter, C; Ramadori, G
      Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-alpha and TGF-beta 1

      JOURNAL OF HEPATOLOGY
    63. Miller, KD; Sledge, GW
      Toward checkmate: Biology and breast cancer therapy for the new millennium

      INVESTIGATIONAL NEW DRUGS
    64. Perez, JC; Sanchez, EE
      Natural protease inhibitors to hemorrhagins in snake venoms and their potential use in medicine

      TOXICON
    65. Gallery, EDM; Campbell, S; Arkell, J; Nguyen, M; Jackson, CJ
      Preeclamptic decidual microvascular endothelial cells express lower levelsof matrix metalloproteinase-1 than normals

      MICROVASCULAR RESEARCH
    66. Curran, S; Murray, GI
      Matrix metalloproteinases in tumour invasion and metastasis

      JOURNAL OF PATHOLOGY
    67. Kraling, BM; Wiederschain, DG; Boehm, T; Rehn, M; Mulliken, JB; Moses, MA
      The role of matrix metalloproteinase activity in the maturation of human capillary endothelial cells in vitro

      JOURNAL OF CELL SCIENCE
    68. Prontera, C; Mariani, B; Rossi, C; Poggi, A; Rotilio, D
      Inhibition of gelatinase A (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma

      INTERNATIONAL JOURNAL OF CANCER
    69. Dhanaraj, V; Williams, MG; Ye, QZ; Molina, F; Johnson, LL; Ortwine, DF; Pavlovsky, A; Rubin, JR; Skeean, RW; White, AD; Humblet, C; Hupe, DJ; Blundell, TL
      X-ray structure of gelatinase A catalytic domain complexed with a hydroxamate inhibitor

      CROATICA CHEMICA ACTA
    70. Rohlff, C; Watson, SA; Morris, TM; Skelton, L; Jackman, AL; Page, MJ
      A novel, orally administered nucleoside analogue, OGT 719, inhibits the liver invasive growth of a human colorectal tumor, C170HM2

      CANCER RESEARCH
    71. Yoshikawa, T; Saitoh, M; Tsuburaya, A; Kobayashi, O; Sairenji, M; Motohashi, H; Yanoma, S; Noguchi, Y
      Tissue inhibitor of matrix metalloproteinase-1 in the plasma of patients with gastric carcinoma - A possible marker for serosal invasion and metastasis

      CANCER
    72. Watson, SA; Morris, TM; Collins, HM; Bawden, LJ; Hawkins, K; Bone, EA
      Inhibition of tumour growth by marimastat in a human xenograft model of gastric cancer: relationship with levels of circulating CEA

      BRITISH JOURNAL OF CANCER
    73. MacDougall, JR; Bani, MR; Lin, Y; Muschel, RJ; Kerbel, RS
      'Proteolytic switching': opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpression

      BRITISH JOURNAL OF CANCER
    74. Fajardo, I; Quesada, AR; de Castro, IN; Sanchez-Jimenez, F; Medina, MA
      A comparative study of the effects of genistein and 2-methoxyestradiol on the proteolytic balance and tumour cell proliferation

      BRITISH JOURNAL OF CANCER
    75. Baker, AH; George, SJ; Zaltsman, AB; Murphy, G; Newby, AC
      Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3

      BRITISH JOURNAL OF CANCER
    76. LOWE C
      TUMOR-NECROSIS-FACTOR-ALPHA ANTAGONISTS AND THEIR THERAPEUTIC APPLICATIONS

      Expert opinion on therapeutic patents
    77. Yaguchi, T; Fukuda, Y; Ishizaki, M; Yamanaka, N
      Immunohistochemical and gelatin zymography studies for matrix metalloproteinases in bleomycin-induced pulmonary fibrosis

      PATHOLOGY INTERNATIONAL
    78. KUIPER RAJ; SCHELLENS JHM; BLIJHAM GH; BEIJNEN JH; VOEST EE
      CLINICAL RESEARCH ON ANTIANGIOGENIC THERAPY

      Pharmacological research
    79. STACK MS; ELLERBROEK SM; FISHMAN DA
      THE ROLE OF PROTEOLYTIC-ENZYMES IN THE PATHOLOGY OF EPITHELIAL OVARIAN-CARCINOMA (REVIEW)

      International journal of oncology
    80. NELIMARKKA LO; NIKKARI ST; RAVANTI LS; KAHARI VM; JARVELAINEN HT
      COLLAGENASE-1, STROMELYSIN-1 AND 92 KDA GELATINASE ARE ASSOCIATED WITH TUMOR-NECROSIS-FACTOR-ALPHA INDUCED MORPHOLOGICAL CHANGE OF HUMAN ENDOTHELIAL-CELLS IN-VITRO

      Matrix biology
    81. MASSOVA I; KOTRA LP; FRIDMAN R; MOBASHERY S
      MATRIX METALLOPROTEINASES - STRUCTURES, EVOLUTION, AND DIVERSIFICATION

      The FASEB journal
    82. DIMITROFF CJ; SHARMA A; BERNACKI RJ
      CANCER METASTASIS - A SEARCH FOR THERAPEUTIC INHIBITION

      Cancer investigation
    83. EPPS DE; POORMAN RA; PETZOLD GL; STUCHLY CW; LABORDE AL; VANDRIE JH
      THE CONSTITUENT TRYPTOPHANS AND BISANS AS FLUORESCENT-PROBES OF THE ACTIVE-SITE AND OF A SECONDARY BINDING-SITE OF STROMELYSIN-1 (MMP3)

      Journal of protein chemistry
    84. BU W; TANG ZY; SUN FX; YE SL; LIU KD; XUE Q; CHEN J; GAO DM
      EFFECTS OF MATRIX METALLOPROTEINASE INHIBITOR BB-94 ON LIVER-CANCER GROWTH AND METASTASIS IN A PATIENT-LIKE ORTHOTOPIC MODEL LCI-D20

      Hepato-gastroenterology
    85. ZETTER BR
      ANGIOGENESIS AND TUMOR-METASTASIS

      Annual review of medicine
    86. EMENAKER NJ; BASSON MD
      SHORT-CHAIN FATTY-ACIDS INHIBIT HUMAN (SW1116) COLON-CANCER CELL INVASION BY REDUCING UROKINASE PLASMINOGEN-ACTIVATOR ACTIVITY AND STIMULATING TIMP-1 AND TIMP-2 ACTIVITIES, RATHER THAN VIA MMP MODULATION

      The Journal of surgical research (Print)
    87. LEBER TM; BALKWILL FR
      REGULATION OF MONOCYTE MMP-9 PRODUCTION BY TNF-ALPHA AND A TUMOR-DERIVED SOLUBLE FACTOR (MMPSF)

      British Journal of Cancer
    88. STEINMEYER J; DAUFELDT S; TAIWO YO
      PHARMACOLOGICAL EFFECT OF TETRACYCLINES ON PROTEOGLYCANASES FROM INTERLEUKIN-1-TREATED ARTICULAR-CARTILAGE

      Biochemical pharmacology
    89. BASSET P; BELLOCQ JP; LEFEBVRE O; NOEL A; CHENARD MP; WOLF C; ANGLARD P; RIO MC
      STROMELYSIN-3 - A PARADIGM FOR STROMA-DERIVED FACTORS IMPLICATED IN CARCINOMA PROGRESSION

      Critical reviews in oncology/hematology
    90. JANUSZ MJ; HARE CM; DURHAM SL; WOESSNER RD
      HUMAN CHONDROSARCOMA CELLS STABLY TRANSFECTED WITH A STROMELYSIN (MMP-3) PROMOTER REPORTER CONSTRUCT PROVIDE A METHOD OF ASSESSING TRANSCRIPTIONAL INHIBITORS

      Inflammation research
    91. BURKE F; EAST N; UPTON C; PATEL K; BALKWILL FR
      INTERFERON-GAMMA INDUCES CELL-CYCLE ARREST AND APOPTOSIS IN A MODEL OF OVARIAN-CANCER - ENHANCEMENT OF EFFECT BY BATIMASTAT

      European journal of cancer
    92. VRANKA JA; JOHNSON E; ZHU XH; SHEPARDSON A; ALEXANDER JP; BRADLEY JMB; WIRTZ MK; WELEBER RG; KLEIN ML; ACOTT TS
      DISCRETE EXPRESSION AND DISTRIBUTION PATTERN OF TIMP-3 IN THE HUMAN RETINA AND CHOROID

      Current eye research
    93. KASAHARA A; HAYASHI N; MOCHIZUKI K; OSHITA M; KATAYAMA K; KATO M; MASUZAWA M; YOSHIHARA H; NAITO M; MIYAMOTO T; INOUE A; ASAI A; HIJIOKA T; FUSAMOTO H; KAMADA T
      CIRCULATING MATRIX METALLOPROTEINASE-2 AND TISSUE INHIBITOR OF METALLOPROTEINASE-1 AS SERUM MARKERS OF FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS-C - RELATIONSHIP TO INTERFERON RESPONSE

      Journal of hepatology
    94. PLUDA JM
      TUMOR-ASSOCIATED ANGIOGENESIS - MECHANISMS, CLINICAL IMPLICATIONS, AND THERAPEUTIC STRATEGIES

      Seminars in oncology
    95. WALTHER MM; KLEINER DE; LUBENSKY IA; POZZATTI R; NYGUEN T; GNARRA JR; HURLEY K; VENZON D; LINEHAN WM; STETLERSTEVENSON WG
      PROGELATINASE-A MESSENGER-RNA EXPRESSION IN CELL-LINES DERIVED FROM TUMORS IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA CORRELATES INVERSELY WITH SURVIVAL

      Urology
    96. MORIMOTO Y; NISHIKAWA K; OHASHI M
      KB-R7785, A NOVEL MATRIX METALLOPROTEINASE INHIBITOR, EXERTS ITS ANTIDIABETIC EFFECT BY INHIBITING TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION

      Life sciences
    97. DORTHO MP; WILL H; ATKINSON S; BUTLER G; MESSENT A; GAVRILOVIC J; SMITH B; TIMPL R; ZARDI L; MURPHY G
      MEMBRANE-TYPE MATRIX METALLOPROTEINASE-1 AND METALLOPROTEINASE-2 EXHIBIT BROAD-SPECTRUM PROTEOLYTIC CAPACITIES COMPARABLE TO MANY MATRIX METALLOPROTEINASES

      European journal of biochemistry
    98. STEINMEYER J; DAUFELDT S
      PHARMACOLOGICAL INFLUENCE OF ANTIRHEUMATIC DRUGS ON PROTEOGLYCANASES FROM INTERLEUKIN-1 TREATED ARTICULAR-CARTILAGE

      Biochemical pharmacology
    99. JONES CL
      MATRIX DEGRADATION IN RENAL-DISEASE

      Nephrology
    100. ZUBAIR AC; ALI SA; REES RC; GOEPEL JR; GOYNS MH
      INVESTIGATION OF THE EFFECT OF BB-94 (BATIMASTAT) ON THE COLONIZATIONPOTENTIAL OF HUMAN LYMPHOMA-CELLS IN SCID MICE

      Cancer letters


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/02/20 alle ore 11:46:06